Hinge Health, Inc. (HNGE) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $5.81B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Daniel A. Perez |
| IPO Date | 2025-05-22 | CAGR | 41.71% |
| Employees | 1,437 | Website | www.hingehealth.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.01% | Total Yield | 0.01% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $4.56B | P/E | 38.52 | Forward P/E | 22.08 | PEG | — |
| P/S | 179872.43 | P/B | 379280.9 | P/CF | 563936.53 | P/FCF | 564402.63 |
| Sales | $646.34M | Sales 1Y | 49.78% | Sales 3Y | — | Sales 5Y | — |
| EPS | $1.95 | EPS 1Y | — | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | 6.78% | EPS QoQ | 10.81% | Sales QoQ Avg | 10.17% | EPS QoQ Avg | -586.55% |
| Gross Margin | 80.96% | Operating Margin | -81.6% | Profit Margin | -95.07% | ROCE | -167.82% |
| ROA | -84% | ROE | -167% | Altman Z Score | 5.31 | Piotroski Score | 4 |
| Current Ratio | 1.22 | Quick Ratio | 1.19 | Cash Ratio | 0.45 | Op. CF Ratio | 0.1 |
| Debt/Equity | 0.02 | Debt/Assets | 0.01 | Lt Debt/Equity | 0.01 | Lt Debt/Cap. | — |
| Intrst Cov. | — | Inventory Turnover | 8.69 | Asset Turnover | 0.89 | Receivables Turnover | 5.62 |
| Enterprise Value | $4.56B | P/E Ratio | 38.52 |
| Forward P/E | 22.08 | PEG Ratio | — |
| P/S Ratio | 179872.43 | P/B Ratio | 379280.9 |
| P/CF Ratio | 563936.53 | P/FCF Ratio | 564402.63 |
| EPS | $1.95 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 49.78% | Gross Margin | 0.81% |
| Operating Margin | -0.82% | Profit Margin | -0.95% |
| ROE | -1.67% | ROA | -0.84% |
| ROCE | -1.68% | Current Ratio | 1.22 |
| Quick Ratio | 1.19 | Cash Ratio | 0.45 |
| Debt/Equity | 0.02 | Interest Coverage | — |
| Altman Z Score | 5.31 | Piotroski Score | 4 |
Hinge Health, Inc. (HNGE) valuation & financials
Hinge Health, Inc. (HNGE) has a market capitalization of $5.81B and trades at a price-to-earnings ratio of 38.5. It operates in the Healthcare sector (Medical - Healthcare Information Services).
Hinge Health, Inc.'s revenue grew +49.8% over the last year.
Hinge Health, Inc.'s next earnings report is scheduled for August 4, 2026 after market close; analysts estimate EPS of $0.59.
Hinge Health, Inc. (HNGE) — frequently asked questions
When does Hinge Health, Inc. (HNGE) report earnings next?
Hinge Health, Inc. is expected to report earnings on August 4, 2026 after market close. Analysts estimate EPS of $0.59.
What is Hinge Health, Inc.'s market cap?
Hinge Health, Inc. (HNGE) has a market capitalization of $5.81B.
What is HNGE's P/E ratio?
Hinge Health, Inc. trades at a price-to-earnings ratio of 38.5, with trailing twelve-month EPS of $1.95.
How fast is Hinge Health, Inc. growing?
Hinge Health, Inc.'s revenue grew +49.8% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)